Previous studies have already undertaken the kinetic characterization of these inhibitors against different ALDH isoforms, and some of them have shown promising results in addressing various cancer types, highlighting their potential for broader therapeutic applications [49,50,51,52,53,54]. This evidence concerns the gene LDHA and cancer.